reviewgastrointestinal hormonesfunctionsregulationsynthesisprocesseating behaviorобзоргастроинтестинальные гормоныфункциирегуляциясинтезпроцесспищевое поведение1.Гроссман М. Желудочно-кишечные гормоны и патология пищеварительной системы. М.: Медицина; 1981.2.Abdalla E. E. Gastrin, secretin, GIP and VIP alter levels of IL-2 and IFN-gamma in human peripheral blood mononuclear cells under various culture conditions. Iran. J. Immunol. 2008; 5 (2): 107-114.3.Уголев А. М., Радбиль О. С. Гормоны пищеварительной системы / Под ред. С. Т. Метельского. М.: Наука; 1995.4.Holst J. J. Hormonal regulation of digestive secretion. In: Desnuelle P., ed. Molecular and cellular basis of digestion. Amsterdam: Elsevier; 1986. 79-112.5.Полак Д. М. (ред.) Физиология и патофизиология желудочно-кишечного тракта. М.: Медицина; 1989.6.Cummings D. E., Overduin J. Gastrointestinal regulation of food intake. J. Clin. Invest. 2007; 117 (1): 13-23.7.Date Y., Nakazato M., Murakami N. et al. Ghrelin acts in the central nervous system to stimulate gastric acid secretion. Biochem. Biophys. Res. Commun. 2001; 280: 904-907.8.Dockray G. J., Varro A., Dimaline R., Wang T. The gastrins: their production and biological activities. Annu. Rev. Physiol. 2001; 63: 119-139.9.Ashust H. L., Varro A., Dimaline R. Regulation of mammalian gastrin/CCK receptor (CCK2r) expression in vitro and in vivo. Exp. Physiol. 2008; 93 (2): 223-236.10.Colucci R., Blndizzi C., Tanini M. et al. Gastrin promotes human colon cancer cell growth via CCK-2 receptor-mediated cyclooxygenase-2 induction and prostaglandin E2 production. Br. J. Pharmacol. 2005; 144 (3): 338-348.11.Beales I. L. P. Regulation of gastric function by gastrin releasing peptide. Gut 2002; 50 (6): 897-898.12.Lendel I., Manni A., Ruggiero F. M. Novel association of duodenal gastrinoma and atrophic gastritis: case report and literature review. Endocr. Pract. 2007; 13 (7): 770-775.13.Ваананен Х., Ваухконен М., Хэлске Т. и др. Неэндоскопическая диагностика атрофического гастрита на основании анализа крови: корреляция между результатами гистологического исследования желудка и уровнями гастрина-17 и пепсиногена I в сыворотке. Клин. перспект. гастроэнтерол., гепатол. 2003; 4: 26-32.14.Di Mario F., Cavallaro L. G. Non-invasive test in gastric diseases. Dig. Liver Dis. 2008; 40 (7): 523-530.15.Haj-Sheykholeslami A., Rakhshani N., Amirzargar A. et al. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis. Clin. Gastroenterol. Hepatol. 2008; 6 (2): 174-179.16.Brazeau P., Vale W., Burgus R. et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973; 179: 77-79.17.Matson C. A., Reid D. F., Cannon T. A., Ritter R. C. Cholecystokinin and leptin act synergitically to reduce body weight. Am. J. Physiol. 2000; 278: 1275-1278.18.Fykse V., Coy D. H., Waldum H. L., Sandvick A. K. Somatostatin-receptor 2 (sst2)-mediated effects of endogenous somatostatin on exocrine and endocrine of the rat stomach. Br J. Pharmacol. 2005; 144 (3): 416-421.19.Moran T. H., Kinzig K. P. Gastrointestinal safety signals II. Cholecystokinin. Am. J. Physiol. 2004; 286: 383-395.20.Rossovski W. J., Cheng B. L., Jiang N. Y., Coy D. H. Examination of somatostatin involvement in the inhibitory action of GIP, GLP-1, amylin and adrenomedullin on gastric and release using a new SRIF antagonist analogue. Br. J. Pharmacol. 1998; 125: 1081-1087.21.Яхонтова О. И., Шубина М. Э. Вазоактивный интестинальный пептид и его изменение при хронических гепатитах и циррозе печени. Рос. гастроэнтерол. журн. 1998; 4: 40-51.22.Климов П. К., Марьянович А. Т., Поляков Е. Л. и др. Физиологические эффекты бомбезина. Физиол. журн. 1985; 2: 145-170.23.Petronillo F., Roesler R., Schwartsmann J. et al. Gastrin-releasing peptide receptor as a molecular target for inflammatory diseases. Inflamm. Allergy Drug Targets 2007; 6 (4): 197-200.24.Sonlee D. W., Merser D. W. Bombesin-induced gastroprotection. Ann. Surg. 2005; 241 (2): 227-231.25.Grosell M., O'Donnell M. J., Wood C. M. Hepatic versus gallbladder bile composition: in vivo transport physiology of the gallbladder in rainbow trout. J. Biol. Chem. 2000; 278 (6): R1674-R1684.26.Beglinger C., Degen L. Fat in the intestine as a regulator of appetite - role of CCK. Physiol. Behav. 2004; 83 (4): 617-621.27.Chen D., Zhao C., Zhao M. et al. Differentiation of gastric ECL cell is altered in CCK2 receptor-deficient mice. Gastroenterology 2003; 123 (2): 577-585.28.Ткаченко Е. В. Роль простагландинов и конституциональных гормонов в патогенезе хронических заболеваний гепатобилиарной системы: Автореф. дис. ... д-ра мед. наук. М.; 2006.29.Strader A. D., Woods S. C. Gastrointestinal hormones and food intake. Gastroenterology 2005; 128: 175-191.30.Tsunoda Y., Yao H., Park J., Owyang C. Cholecystokinin synthesizes and secretes leptin in isolated canine gastric chief cells. Biochem. Biophys. Res. Commun. 2003; 310: 681-684.31.Kojima M., Nosoda H., Date Y. et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660.32.Cowley M. A., Smitr R. G., Diano S. et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003; 37: 649-661.33.Wu J. T., Kral J. G. Ghrelin. Integrative neuroendocrine peptide in health and disease. Ann. Surg. 2004; 239 (4): 464-474.34.Hagg A., Hoch A., Geler F. et al. Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J. Clin. Endocrinol. 2003; 88: 174-178.35.Zhang Z. H., Wu S. D., Su Y. et al. Differences and significance of motilin, vasoactive intestinal peptide and gastrin in blood and gallbladder tissues of patients with gallstones. Hepatobiliary Pancreat. Dis. Int. 2008; 7 (1): 58-64.